Selected research
Industry Research
Anti-vertigo Drugs Industry Research Report 2026
Market perspective
The global Anti-vertigo Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-vertigo Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-vertigo Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-vertigo Drugs include Zhejiang Proconyu Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Weifang Zhongshi Pharmaceutical Co., Ltd., Tianfang Pharmaceutical Co., Ltd., Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Shandong Xinyi Pharmaceutical Co., Ltd., Renhetang Pharmaceutical Co., Ltd. and Jiangsu Sihuan Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-vertigo Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-vertigo Drugs Market by Company
Zhejiang Proconyu Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Weifang Zhongshi Pharmaceutical Co., Ltd.
Tianfang Pharmaceutical Co., Ltd.
Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
Shandong Xinyi Pharmaceutical Co., Ltd.
Renhetang Pharmaceutical Co., Ltd.
Jiangsu Sihuan Biopharmaceutical Co., Ltd.
Jinan Yongning Pharmaceutical Co., Ltd.
China Resources Shuanghe Pharmaceutical Co., Ltd.
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
Heilongjiang Yidahong Pharmaceutical Co., Ltd.
Henan Zhongjie Pharmaceutical Co., Ltd.
Guangdong Lingnan Pharmaceutical Co., Ltd.
Guangdong Bangmin Pharmaceutical Co., Ltd.
Beijing Juneng Pharmaceutical Co., Ltd.
Wellona Pharma
SAVAL Pharma
Santa Cruz Biotechnology, Inc
Kent Pharmaceuticals Ltd
Kabir Lifesciences
AdvaCare Pharma
Anti-vertigo Drugs Segment by Type
Betahistine
Diphenidol
Flunarizine
Anti-vertigo Drugs Segment by Application
Clinic
Hospital
Pharmacy
Other
Anti-vertigo Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-vertigo Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-vertigo Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-vertigo Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-vertigo Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-vertigo Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-vertigo Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Anti-vertigo Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Anti-vertigo Drugs Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Anti-vertigo Drugs Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Anti-vertigo Drugs Revenue of Manufacturers (2021-2026)
Table 9. Global Anti-vertigo Drugs Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Anti-vertigo Drugs Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Anti-vertigo Drugs Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Anti-vertigo Drugs, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Anti-vertigo Drugs, Product Type & Application
Table 14. Global Anti-vertigo Drugs Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Anti-vertigo Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Zhejiang Proconyu Pharmaceutical Co., Ltd. Company Information
Table 19. Zhejiang Proconyu Pharmaceutical Co., Ltd. Business Overview
Table 20. Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 22. Zhejiang Proconyu Pharmaceutical Co., Ltd. Recent Developments
Table 23. Southwest Pharmaceutical Co., Ltd. Company Information
Table 24. Southwest Pharmaceutical Co., Ltd. Business Overview
Table 25. Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 27. Southwest Pharmaceutical Co., Ltd. Recent Developments
Table 28. Weifang Zhongshi Pharmaceutical Co., Ltd. Company Information
Table 29. Weifang Zhongshi Pharmaceutical Co., Ltd. Business Overview
Table 30. Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 32. Weifang Zhongshi Pharmaceutical Co., Ltd. Recent Developments
Table 33. Tianfang Pharmaceutical Co., Ltd. Company Information
Table 34. Tianfang Pharmaceutical Co., Ltd. Business Overview
Table 35. Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 37. Tianfang Pharmaceutical Co., Ltd. Recent Developments
Table 38. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Company Information
Table 39. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Business Overview
Table 40. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 42. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Developments
Table 43. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
Table 44. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
Table 45. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 47. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
Table 48. Shandong Xinyi Pharmaceutical Co., Ltd. Company Information
Table 49. Shandong Xinyi Pharmaceutical Co., Ltd. Business Overview
Table 50. Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 52. Shandong Xinyi Pharmaceutical Co., Ltd. Recent Developments
Table 53. Renhetang Pharmaceutical Co., Ltd. Company Information
Table 54. Renhetang Pharmaceutical Co., Ltd. Business Overview
Table 55. Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 57. Renhetang Pharmaceutical Co., Ltd. Recent Developments
Table 58. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Company Information
Table 59. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Business Overview
Table 60. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 62. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Recent Developments
Table 63. Jinan Yongning Pharmaceutical Co., Ltd. Company Information
Table 64. Jinan Yongning Pharmaceutical Co., Ltd. Business Overview
Table 65. Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 67. Jinan Yongning Pharmaceutical Co., Ltd. Recent Developments
Table 68. China Resources Shuanghe Pharmaceutical Co., Ltd. Company Information
Table 69. China Resources Shuanghe Pharmaceutical Co., Ltd. Business Overview
Table 70. China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 72. China Resources Shuanghe Pharmaceutical Co., Ltd. Recent Developments
Table 73. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
Table 74. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview
Table 75. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 77. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments
Table 78. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Company Information
Table 79. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Business Overview
Table 80. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 82. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Recent Developments
Table 83. Henan Zhongjie Pharmaceutical Co., Ltd. Company Information
Table 84. Henan Zhongjie Pharmaceutical Co., Ltd. Business Overview
Table 85. Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 87. Henan Zhongjie Pharmaceutical Co., Ltd. Recent Developments
Table 88. Guangdong Lingnan Pharmaceutical Co., Ltd. Company Information
Table 89. Guangdong Lingnan Pharmaceutical Co., Ltd. Business Overview
Table 90. Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 92. Guangdong Lingnan Pharmaceutical Co., Ltd. Recent Developments
Table 93. Guangdong Bangmin Pharmaceutical Co., Ltd. Company Information
Table 94. Guangdong Bangmin Pharmaceutical Co., Ltd. Business Overview
Table 95. Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 97. Guangdong Bangmin Pharmaceutical Co., Ltd. Recent Developments
Table 98. Beijing Juneng Pharmaceutical Co., Ltd. Company Information
Table 99. Beijing Juneng Pharmaceutical Co., Ltd. Business Overview
Table 100. Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
Table 102. Beijing Juneng Pharmaceutical Co., Ltd. Recent Developments
Table 103. Wellona Pharma Company Information
Table 104. Wellona Pharma Business Overview
Table 105. Wellona Pharma Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Wellona Pharma Anti-vertigo Drugs Product Portfolio
Table 107. Wellona Pharma Recent Developments
Table 108. SAVAL Pharma Company Information
Table 109. SAVAL Pharma Business Overview
Table 110. SAVAL Pharma Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. SAVAL Pharma Anti-vertigo Drugs Product Portfolio
Table 112. SAVAL Pharma Recent Developments
Table 113. Santa Cruz Biotechnology, Inc Company Information
Table 114. Santa Cruz Biotechnology, Inc Business Overview
Table 115. Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Product Portfolio
Table 117. Santa Cruz Biotechnology, Inc Recent Developments
Table 118. Kent Pharmaceuticals Ltd Company Information
Table 119. Kent Pharmaceuticals Ltd Business Overview
Table 120. Kent Pharmaceuticals Ltd Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Kent Pharmaceuticals Ltd Anti-vertigo Drugs Product Portfolio
Table 122. Kent Pharmaceuticals Ltd Recent Developments
Table 123. Kabir Lifesciences Company Information
Table 124. Kabir Lifesciences Business Overview
Table 125. Kabir Lifesciences Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Kabir Lifesciences Anti-vertigo Drugs Product Portfolio
Table 127. Kabir Lifesciences Recent Developments
Table 128. AdvaCare Pharma Company Information
Table 129. AdvaCare Pharma Business Overview
Table 130. AdvaCare Pharma Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. AdvaCare Pharma Anti-vertigo Drugs Product Portfolio
Table 132. AdvaCare Pharma Recent Developments
Table 133. Global Anti-vertigo Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 134. Global Anti-vertigo Drugs Sales by Region (2021-2026) & (K Units)
Table 135. Global Anti-vertigo Drugs Sales Market Share by Region (2021-2026)
Table 136. Global Anti-vertigo Drugs Sales by Region (2027-2032) & (K Units)
Table 137. Global Anti-vertigo Drugs Sales Market Share by Region (2027-2032)
Table 138. Global Anti-vertigo Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 139. Global Anti-vertigo Drugs Revenue Market Share by Region (2021-2026)
Table 140. Global Anti-vertigo Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 141. Global Anti-vertigo Drugs Revenue Market Share by Region (2027-2032)
Table 142. North America Anti-vertigo Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. North America Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units)
Table 144. North America Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units)
Table 145. North America Anti-vertigo Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 146. North America Anti-vertigo Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 147. Europe Anti-vertigo Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. Europe Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units)
Table 149. Europe Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units)
Table 150. Europe Anti-vertigo Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 151. Europe Anti-vertigo Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 152. Asia Pacific Anti-vertigo Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Asia Pacific Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units)
Table 154. Asia Pacific Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units)
Table 155. Asia Pacific Anti-vertigo Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 156. Asia Pacific Anti-vertigo Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 157. South America Anti-vertigo Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. South America Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units)
Table 159. South America Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units)
Table 160. South America Anti-vertigo Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 161. South America Anti-vertigo Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 162. Middle East and Africa Anti-vertigo Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. Middle East and Africa Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units)
Table 164. Middle East and Africa Anti-vertigo Drugs Sales by Country (2027-2032) & (K Units)
Table 165. Middle East and Africa Anti-vertigo Drugs Revenue by Country (2021-2026) & (US$ Million)
Table 166. Middle East and Africa Anti-vertigo Drugs Revenue by Country (2027-2032) & (US$ Million)
Table 167. Global Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units)
Table 168. Global Anti-vertigo Drugs Sales by Type (2027-2032) & (K Units)
Table 169. Global Anti-vertigo Drugs Sales Market Share by Type (2021-2026)
Table 170. Global Anti-vertigo Drugs Sales Market Share by Type (2027-2032)
Table 171. Global Anti-vertigo Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 172. Global Anti-vertigo Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 173. Global Anti-vertigo Drugs Revenue Market Share by Type (2021-2026)
Table 174. Global Anti-vertigo Drugs Revenue Market Share by Type (2027-2032)
Table 175. Global Anti-vertigo Drugs Price by Type (2021-2026) & (US$/Unit)
Table 176. Global Anti-vertigo Drugs Price by Type (2027-2032) & (US$/Unit)
Table 177. Global Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units)
Table 178. Global Anti-vertigo Drugs Sales by Application (2027-2032) & (K Units)
Table 179. Global Anti-vertigo Drugs Sales Market Share by Application (2021-2026)
Table 180. Global Anti-vertigo Drugs Sales Market Share by Application (2027-2032)
Table 181. Global Anti-vertigo Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 182. Global Anti-vertigo Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 183. Global Anti-vertigo Drugs Revenue Market Share by Application (2021-2026)
Table 184. Global Anti-vertigo Drugs Revenue Market Share by Application (2027-2032)
Table 185. Global Anti-vertigo Drugs Price by Application (2021-2026) & (US$/Unit)
Table 186. Global Anti-vertigo Drugs Price by Application (2027-2032) & (US$/Unit)
Table 187. Key Raw Materials
Table 188. Raw Materials Key Suppliers
Table 189. Anti-vertigo Drugs Distributors List
Table 190. Anti-vertigo Drugs Customers List
Table 191. Anti-vertigo Drugs Industry Trends
Table 192. Anti-vertigo Drugs Industry Drivers
Table 193. Anti-vertigo Drugs Industry Restraints
Table 194. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Anti-vertigo Drugs Product Image
Figure 5. Global Anti-vertigo Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Anti-vertigo Drugs Market Size (2021-2032) & (US$ Million)
Figure 7. Global Anti-vertigo Drugs Sales (2021-2032) & (K Units)
Figure 8. Global Anti-vertigo Drugs Average Price (US$/Unit) & (2021-2032)
Figure 9. Betahistine Product Image
Figure 10. Diphenidol Product Image
Figure 11. Flunarizine Product Image
Figure 12. Clinic Product Image
Figure 13. Hospital Product Image
Figure 14. Pharmacy Product Image
Figure 15. Other Product Image
Figure 16. Global Anti-vertigo Drugs Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Anti-vertigo Drugs, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Anti-vertigo Drugs Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Anti-vertigo Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Anti-vertigo Drugs Sales by Region in 2025
Figure 22. Global Anti-vertigo Drugs Revenue by Region in 2025
Figure 23. North America Anti-vertigo Drugs Market Size by Country in 2025
Figure 24. North America Anti-vertigo Drugs Sales Market Share by Country (2021-2032)
Figure 25. North America Anti-vertigo Drugs Revenue Market Share by Country (2021-2032)
Figure 26. United States Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Anti-vertigo Drugs Market Size by Country in 2025
Figure 30. Europe Anti-vertigo Drugs Sales Market Share by Country (2021-2032)
Figure 31. Europe Anti-vertigo Drugs Revenue Market Share by Country (2021-2032)
Figure 32. Germany Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Anti-vertigo Drugs Market Size by Country in 2025
Figure 43. Asia Pacific Anti-vertigo Drugs Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Anti-vertigo Drugs Revenue Market Share by Country (2021-2032)
Figure 45. China Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Anti-vertigo Drugs Market Size by Country in 2025
Figure 54. South America Anti-vertigo Drugs Sales Market Share by Country (2021-2032)
Figure 55. South America Anti-vertigo Drugs Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Anti-vertigo Drugs Market Size by Country in 2025
Figure 60. Middle East and Africa Anti-vertigo Drugs Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Anti-vertigo Drugs Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Anti-vertigo Drugs Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Anti-vertigo Drugs Sales Market Share by Type (2021-2032)
Figure 68. Global Anti-vertigo Drugs Revenue Market Share by Type (2021-2032)
Figure 69. Global Anti-vertigo Drugs Price (US$/Unit) by Type (2021-2032)
Figure 70. Global Anti-vertigo Drugs Sales Market Share by Application (2021-2032)
Figure 71. Global Anti-vertigo Drugs Revenue Market Share by Application (2021-2032)
Figure 72. Global Anti-vertigo Drugs Price (US$/Unit) by Application (2021-2032)
Figure 73. Anti-vertigo Drugs Value Chain
Figure 74. Anti-vertigo Drugs Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Anti-vertigo Drugs Industry Opportunities and Challenges
Scope & coverage.
Types
- Betahistine
- Diphenidol
- Flunarizine
Applications
- Clinic
- Hospital
- Pharmacy
- Other
Companies covered
- Zhejiang Proconyu Pharmaceutical Co., Ltd.
- Southwest Pharmaceutical Co., Ltd.
- Weifang Zhongshi Pharmaceutical Co., Ltd.
- Tianfang Pharmaceutical Co., Ltd.
- Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
- Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
- Shandong Xinyi Pharmaceutical Co., Ltd.
- Renhetang Pharmaceutical Co., Ltd.
- Jiangsu Sihuan Biopharmaceutical Co., Ltd.
- Jinan Yongning Pharmaceutical Co., Ltd.
- China Resources Shuanghe Pharmaceutical Co., Ltd.
- Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
- Heilongjiang Yidahong Pharmaceutical Co., Ltd.
- Henan Zhongjie Pharmaceutical Co., Ltd.
- Guangdong Lingnan Pharmaceutical Co., Ltd.
- Guangdong Bangmin Pharmaceutical Co., Ltd.
- Beijing Juneng Pharmaceutical Co., Ltd.
- Wellona Pharma
- SAVAL Pharma
- Santa Cruz Biotechnology, Inc
- Kent Pharmaceuticals Ltd
- Kabir Lifesciences
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-vertigo Drugs Market Size (2021-2032)
- 2.2.2 Global Anti-vertigo Drugs Sales (2021-2032)
- 2.2.3 Global Anti-vertigo Drugs Market Average Price (2021-2032)
- 2.3 Anti-vertigo Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Betahistine
- 2.3.3 Diphenidol
- 2.3.4 Flunarizine
- 2.4 Anti-vertigo Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Pharmacy
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-vertigo Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-vertigo Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anti-vertigo Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-vertigo Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-vertigo Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-vertigo Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-vertigo Drugs, Product Type & Application
- 3.8 Global Manufacturers of Anti-vertigo Drugs, Established Date
- 3.9 Global Anti-vertigo Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Proconyu Pharmaceutical Co., Ltd.
- 4.1.1 Zhejiang Proconyu Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Zhejiang Proconyu Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.1.5 Zhejiang Proconyu Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Southwest Pharmaceutical Co., Ltd.
- 4.2.1 Southwest Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Southwest Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.2.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Weifang Zhongshi Pharmaceutical Co., Ltd.
- 4.3.1 Weifang Zhongshi Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Weifang Zhongshi Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.3.5 Weifang Zhongshi Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Tianfang Pharmaceutical Co., Ltd.
- 4.4.1 Tianfang Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Tianfang Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.4.5 Tianfang Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
- 4.5.1 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.5.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
- 4.6.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.6.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Shandong Xinyi Pharmaceutical Co., Ltd.
- 4.7.1 Shandong Xinyi Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Shandong Xinyi Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.7.5 Shandong Xinyi Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Renhetang Pharmaceutical Co., Ltd.
- 4.8.1 Renhetang Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Renhetang Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.8.5 Renhetang Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
- 4.9.1 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Company Information
- 4.9.2 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Business Overview
- 4.9.3 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.9.5 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Recent Developments
- 4.10 Jinan Yongning Pharmaceutical Co., Ltd.
- 4.10.1 Jinan Yongning Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Jinan Yongning Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.10.5 Jinan Yongning Pharmaceutical Co., Ltd. Recent Developments
- 4.11 China Resources Shuanghe Pharmaceutical Co., Ltd.
- 4.11.1 China Resources Shuanghe Pharmaceutical Co., Ltd. Company Information
- 4.11.2 China Resources Shuanghe Pharmaceutical Co., Ltd. Business Overview
- 4.11.3 China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.11.5 China Resources Shuanghe Pharmaceutical Co., Ltd. Recent Developments
- 4.12 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
- 4.12.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
- 4.12.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview
- 4.12.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.12.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments
- 4.13 Heilongjiang Yidahong Pharmaceutical Co., Ltd.
- 4.13.1 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Company Information
- 4.13.2 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Business Overview
- 4.13.3 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.13.5 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Recent Developments
- 4.14 Henan Zhongjie Pharmaceutical Co., Ltd.
- 4.14.1 Henan Zhongjie Pharmaceutical Co., Ltd. Company Information
- 4.14.2 Henan Zhongjie Pharmaceutical Co., Ltd. Business Overview
- 4.14.3 Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.14.5 Henan Zhongjie Pharmaceutical Co., Ltd. Recent Developments
- 4.15 Guangdong Lingnan Pharmaceutical Co., Ltd.
- 4.15.1 Guangdong Lingnan Pharmaceutical Co., Ltd. Company Information
- 4.15.2 Guangdong Lingnan Pharmaceutical Co., Ltd. Business Overview
- 4.15.3 Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.15.5 Guangdong Lingnan Pharmaceutical Co., Ltd. Recent Developments
- 4.16 Guangdong Bangmin Pharmaceutical Co., Ltd.
- 4.16.1 Guangdong Bangmin Pharmaceutical Co., Ltd. Company Information
- 4.16.2 Guangdong Bangmin Pharmaceutical Co., Ltd. Business Overview
- 4.16.3 Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.16.5 Guangdong Bangmin Pharmaceutical Co., Ltd. Recent Developments
- 4.17 Beijing Juneng Pharmaceutical Co., Ltd.
- 4.17.1 Beijing Juneng Pharmaceutical Co., Ltd. Company Information
- 4.17.2 Beijing Juneng Pharmaceutical Co., Ltd. Business Overview
- 4.17.3 Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
- 4.17.5 Beijing Juneng Pharmaceutical Co., Ltd. Recent Developments
- 4.18 Wellona Pharma
- 4.18.1 Wellona Pharma Company Information
- 4.18.2 Wellona Pharma Business Overview
- 4.18.3 Wellona Pharma Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Wellona Pharma Anti-vertigo Drugs Product Portfolio
- 4.18.5 Wellona Pharma Recent Developments
- 4.19 SAVAL Pharma
- 4.19.1 SAVAL Pharma Company Information
- 4.19.2 SAVAL Pharma Business Overview
- 4.19.3 SAVAL Pharma Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 SAVAL Pharma Anti-vertigo Drugs Product Portfolio
- 4.19.5 SAVAL Pharma Recent Developments
- 4.20 Santa Cruz Biotechnology, Inc
- 4.20.1 Santa Cruz Biotechnology, Inc Company Information
- 4.20.2 Santa Cruz Biotechnology, Inc Business Overview
- 4.20.3 Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Product Portfolio
- 4.20.5 Santa Cruz Biotechnology, Inc Recent Developments
- 4.21 Kent Pharmaceuticals Ltd
- 4.21.1 Kent Pharmaceuticals Ltd Company Information
- 4.21.2 Kent Pharmaceuticals Ltd Business Overview
- 4.21.3 Kent Pharmaceuticals Ltd Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Kent Pharmaceuticals Ltd Anti-vertigo Drugs Product Portfolio
- 4.21.5 Kent Pharmaceuticals Ltd Recent Developments
- 4.22 Kabir Lifesciences
- 4.22.1 Kabir Lifesciences Company Information
- 4.22.2 Kabir Lifesciences Business Overview
- 4.22.3 Kabir Lifesciences Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Kabir Lifesciences Anti-vertigo Drugs Product Portfolio
- 4.22.5 Kabir Lifesciences Recent Developments
- 4.23 AdvaCare Pharma
- 4.23.1 AdvaCare Pharma Company Information
- 4.23.2 AdvaCare Pharma Business Overview
- 4.23.3 AdvaCare Pharma Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 AdvaCare Pharma Anti-vertigo Drugs Product Portfolio
- 4.23.5 AdvaCare Pharma Recent Developments
5 Global Anti-vertigo Drugs Market Scenario by Region
- 5.1 Global Anti-vertigo Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-vertigo Drugs Sales by Region: 2021-2032
- 5.2.1 Global Anti-vertigo Drugs Sales by Region: 2021-2026
- 5.2.2 Global Anti-vertigo Drugs Sales by Region: 2027-2032
- 5.3 Global Anti-vertigo Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Anti-vertigo Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Anti-vertigo Drugs Revenue by Region: 2027-2032
- 5.4 North America Anti-vertigo Drugs Market Facts & Figures by Country
- 5.4.1 North America Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-vertigo Drugs Sales by Country (2021-2032)
- 5.4.3 North America Anti-vertigo Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-vertigo Drugs Market Facts & Figures by Country
- 5.5.1 Europe Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-vertigo Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Anti-vertigo Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-vertigo Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-vertigo Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-vertigo Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-vertigo Drugs Market Facts & Figures by Country
- 5.7.1 South America Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-vertigo Drugs Sales by Country (2021-2032)
- 5.7.3 South America Anti-vertigo Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anti-vertigo Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-vertigo Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-vertigo Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anti-vertigo Drugs Sales by Type (2021-2032)
- 6.1.1 Global Anti-vertigo Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anti-vertigo Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-vertigo Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Anti-vertigo Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-vertigo Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-vertigo Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-vertigo Drugs Sales by Application (2021-2032)
- 7.1.1 Global Anti-vertigo Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anti-vertigo Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-vertigo Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Anti-vertigo Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-vertigo Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-vertigo Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-vertigo Drugs Value Chain Analysis
- 8.1.1 Anti-vertigo Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-vertigo Drugs Production Mode & Process
- 8.2 Anti-vertigo Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-vertigo Drugs Distributors
- 8.2.3 Anti-vertigo Drugs Customers
9 Global Anti-vertigo Drugs Analyzing Market Dynamics
- 9.1 Anti-vertigo Drugs Industry Trends
- 9.2 Anti-vertigo Drugs Industry Drivers
- 9.3 Anti-vertigo Drugs Industry Opportunities and Challenges
- 9.4 Anti-vertigo Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst